In asthma, inflammatory and structural cells contribute to increased bronchoconstriction acutely and more chronically to airway remodelling. Current asthma therapy doesnt inhibit these features satisfactorily. This review discusses Rho-kinase as a potential drug target, since increasing evidence suggests a central role for this pathway in acute and chronic airway hyperresponsiveness.
Keywords: Airway remodelling, airway smooth muscle, airway inflammation, Y-27632, fasudil
Rights & PermissionsPrintExport